The UAE life sciences investment initiative is accelerating with Abu Dhabi’s launch of the HELM cluster. This strategic move aims to transform the emirate into a leading global center for medical innovation.
The Department of Health – Abu Dhabi (DoH), Abu Dhabi Investment Office (ADIO), and Hub71 have formed a strong alliance. Together, they are building the Health, Endurance, Longevity, and Medicine (HELM) cluster to attract top-tier startups and investors.
Importantly, the HELM cluster focuses on biotechnology, MedTech, and digital health. These sectors are central to the broader UAE life sciences investment strategy for sustainable growth.
In addition, the cluster is projected to contribute AED 94 billion to Abu Dhabi’s GDP. It is also expected to create 30,000 jobs by 2045, supporting national economic diversification goals.
To enhance visibility, Hub71 will organize global roadshows and promotional campaigns. Moreover, it will connect startups with venture capitalists, helping expand the life sciences sector in the UAE.
At the same time, ADIO will provide co-investment opportunities and streamlined support services. These incentives make the UAE life sciences investment environment even more appealing to global firms.
Furthermore, Hub71 will help startups access markets and funding quickly. DoH, meanwhile, will ease regulatory processes and offer compliance support for investors and health innovators.
To ensure continued improvement, all three entities will collaborate on policy updates and infrastructure upgrades. This ongoing alignment with international standards will strengthen healthcare investment in the UAE.
Dr. Noura Al Ghaithi emphasized Abu Dhabi’s unique position. She explained that the city offers a full launchpad for innovators—not just a place to invest.
Additionally, Badr Al Olama of ADIO noted how Abu Dhabi supports early-stage innovation. By combining funding, infrastructure, and regulation, the UAE life sciences investment model empowers startups to scale faster.
Likewise, Ahmad Ali Alwan from Hub71 highlighted Abu Dhabi’s vibrant startup community. He stressed how strong partnerships and capital access fuel innovation in global healthcare.
Notably, Abu Dhabi has already achieved $4.2 billion in startup exits and secured $224 million in early-stage funding. These numbers show strong progress in the life sciences sector in the UAE.
Since its launch, DoH has supported 80 healthcare startups. This support helped generate 926 specialized jobs and increased sector growth by 22 percent.
Abu Dhabi Global Health Week also reinforced the UAE’s commitment to medical innovation. The event promoted collaboration, long-term health, and cutting-edge solutions under the theme “Towards Longevity.”
